During the past decade, V.A. Nasonova Research Institute of Rheumatology conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 6 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 5 clinical trials were completed. i.e. 38.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "V.A. Nasonova Research Institute of Rheumatology" #1 sponsor was "Eli Lilly and Company" with 7 trials, followed by "Amgen" with 4 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored, "Biocad" with 3 trials sponsored and "Actelion" with 3 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "V.A. Nasonova Research Institute of Rheumatology" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator and "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "V.A. Nasonova Research Institute of Rheumatology" are "Arthritis, Psoriatic" (6 trials), "Rheumatoid Arthritis" (5 trials), "Axial Spondyloarthritis" (2 trials), "Systemic Lupus Erythematosus" (2 trials) and "Active Systemic Lupus Erythematosus" (1 trials). Many other conditions were trialed in "V.A. Nasonova Research Institute of Rheumatology" in a lesser frequency.

Most popular intervention types in "V.A. Nasonova Research Institute of Rheumatology" are "Drug" (21 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Guselkumab" (5 trials), "Baricitinib" (4 trials), "Ixekizumab" (2 trials) and "Apremilast" (1 trials). Other intervention names were less common.

The vast majority of trials in "V.A. Nasonova Research Institute of Rheumatology" are 21 trials for "All" genders.

Currently, there are NaN active trials in "V.A. Nasonova Research Institute of Rheumatology". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in V.A. Nasonova Research Institute of Rheumatology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in V.A. Nasonova Research Institute of Rheumatology, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".

V.A. Nasonova Research Institute of Rheumatology has several departments that took part in Clinical trials: "SI Sceintific children health center RAMS" - 10 trials, "Institute for Child and Youth Healthcare of Vojvodina" - 9 trials, "Hippokration University Hopsital" - 5 trials, "Emma Children's Hospital, Academic Medical Center" - 3 trials, "Hospital Infantil de México "Federico Gomez"; Rheumatology" - 2 trials, "Paediatric rheumatology Unit" - 2 trials, "State Healthcare Institution Ulyanovsk Regional Clinical Hospital" - 6 trials